Two-Year Responses of Renal Function to First Occupational Lead Exposure
Yu-Ling Yu,Lutgarde Thijs,Dong-Mei Wei,Jesus D. Melgarejo,Cai-Guo Yu,Wen-Yi Yang,Harry A. Roels,Zhen-Yu Zhang,Tim S. Nawrot,Jan A. Staessen
DOI: https://doi.org/10.1016/j.ekir.2022.03.014
IF: 6.234
2022-03-01
Kidney International Reports
Abstract:IntroductionWhether in developed countries lead exposure still contributes to renal impairment is debated, because blood lead (BL) is declining towards pre-industrial levels and because longitudinal studies correlating renal function and BL changes over time are scarce.MethodsThe Study for Promotion of Health in Recycling Lead evaluated the 2-year renal function responses in 251 workers (mean age, 29.7 years) transiting from environmental to occupational exposure. Main study endpoint was the estimated glomerular filtration rate (eGFR) derived from serum creatinine, cystatin C or both (eGFRcrt, eGFRcys, eGFRcc). BL was measured by inductively coupled plasma mass spectrometry (detection limit 0.5 μg/dl).ResultsOver follow-up, mean baseline BL of 4.13 μg/dl increased 3.30-fold. In fully adjusted mixed models, additionally accounting for the within-participant clustering of the 1- and 2-year follow-up data, a 3-fold BL increment was not significantly correlated with changes in eGFR with estimates amounting to -0.86 (95% CI, -2.39, 0.67), -1.58 (-3.34, 0.18) and -1.32 (-2.66, 0.03) ml/min/1.73 m2 for eGFRcrt, eGFRcys or eGFRcc, respectively. Baseline BL and the cumulative lead burden did not materially modify these estimates, but baseline eGFR was a major determinant of eGFR changes showing regression to the mean during follow-up. Responses of serum osmolarity, urinary gravity or the urinary albumin-to-creatinine ratio were also unrelated to the BL increment. The age-related decreases in eGFRcrt, eGFRcys and eGFRcc, were -1.41, -0.96 and -1.10 ml/min/1.73 m2, respectively.ConclusionsIn the current study the 2-year changes in renal function were unrelated to the blood lead increase. However, given the confidence intervals around the point estimates of the changes in eGFRcc and eGFRcys, a larger study with longer follow-up is being planned.
urology & nephrology